Unilife Corp (UNIS) 3.57 $UNIS
Global Prefilled Syringes Market 2013 - 2019
M2 - Tue Apr 15, 8:30AM CDT
Research and Markets (http://www.researchandmarkets.com/research/j3vxcv/prefilled) has announced the addition of the "Global Prefilled Syringes Market 2013 - 2019" report to their offering. The two major segments described in this study are glass-based and plastic-based prefilled syringes. Each of these segments has been analyzed on the basis of their current and future market size in terms of USD million and market volume in terms of million units, considering the macro and micro environmental factors. In addition, the compounded annual growth rate (CAGR) of the overall market and the above segments has also been provided in the report for the forecast period 2013 to 2019, considering 2012 as the base year. Geographically, the market for prefilled syringes has been classified into four regions namely North America, Europe, Asia-Pacific and Rest of the World (RoW). The market size and forecast for each of these regions along with CAGR has also been provided in the report. A detailed qualitative analysis of the major market dynamics such as drivers, restraints and opportunities, along with Porter's five forces analysis and market attractiveness analysis are discussed in the market overview section of the report. The study also suggests a list of recommendations that is likely to help manufacturers in decision making process. The report concludes with a market share analysis of the leading players in the market for prefilled syringes, in terms of percentage share in the year 2012, and company profiles of the key players. The market players profiled in this report are Becton, Dickinson and Company, Gerresheimer AG, Nipro Corporation, Schott AG, Stevanato Group, Baxter, International, Inc., Unilife Corporation, West Pharmaceutical Services, Inc., Bespak, Ypsomed Holding AG and Vetter Pharma International GmbH. Scope of the Report Segment - Glass Prefilled Syringes Market - - By Revenue (USD Million) - - By Volume (Million units) - Plastic Prefilled Syringes Market - - By Revenue (USD Million) - - By Volume (Million units) Key Topics Covered: - Preface - Executive Summary - Global Prefilled Syringes Market Overview - Global Prefilled Syringes Market Revenue (USD Million) and Volume (Million Units), by Segment, 2011 - 2019 - Global Prefilled Syringes Market Revenue (USD Million) and Volume (Million Units), by Geography, 2011 - 2019 - Competitive Landscape - Recommendations - Company Profiles - Baxter International, Inc - Becton, Dickinson & Company - Bespak - Gerresheimer AG - Nipro Corporation - Schott AG - Stevanato Group - Unilife Corporation - Vetter Pharma International GmbH - West Pharmaceutical Services, Inc - Ypsomed Holding AG For more information visit http://www.researchandmarkets.com/research/j3vxcv/prefilled
Health Care Sector Equities Update -- Research on Endologix, Align Technology, Spectranetics, and Unilife
PR Newswire - Mon Apr 14, 8:00AM CDT
The trading session on Friday, April 11, 2014 ended on a lower note as the Dow Jones Industrial Average finished at 16,026.75, down 0.89% and the NASDAQ Composite closed at 3,999.73, down 1.34%. The S&P 500 finished the session 0.95% lower at 1,815.69. The losses were broad based as all the ten sectors posted losses. The S&P 500 Health Care Sector Index finished the day at 644.74, down 1.07%, and the same has declined 2.36% in last three months. Investor-Edge has initiated coverage on the following equities: Endologix Inc. (NASDAQ: ELGX), Align Technology Inc. (NASDAQ: ALGN), Spectranetics Corp. (NASDAQ: SPNC) and Unilife Corp. (NASDAQ: UNIS). Free technical research on ELGX, ALGN, SPNC and UNIS can be downloaded upon signing up at:
Commit To Purchase Unilife Corp. At $2.50, Earn 13.4% Annualized Using Options
StockOptionsChannel.com - Thu Apr 10, 10:51AM CDT
Investors eyeing a purchase of Unilife Corp. shares, but cautious about paying the going market price of $3.62/share, might benefit from considering selling puts among the alternative strategies at their disposal.
European Commission Approves Exelixis Inc.'s Therapy for Thyroid Cancer
ACCESSWIRE - Fri Apr 04, 1:00PM CDT
Exelixis Inc. (NASDAQ:EXEL) enjoyed robust stock volume Apr. 3, with 4,756,727 shares changing hands.
Unilife Down 5.1%, Shares Slide into the Red (UNIS)
Comtex SmarTrend(R) - Fri Mar 28, 10:41AM CDT
Unilife (NASDAQ:UNIS) is one of today's worst performing low-priced stocks, down 5.1% to $4.11 on 1.1x average daily volume. Unilife has traded 1.3 million shares thus far today, vs. average volume of 1.2 million shares per day. The stock has underperformed the Dow (-5.1% to the Dow's 0.7%) and underperformed the S&P 500 (-5.1% to the S&P's 0.8%) during today's trading.
Investors look to Lighten Up on Shares of Unilife, Shares Down 8.5% (UNIS)
Comtex SmarTrend(R) - Mon Mar 24, 11:42AM CDT
Unilife (NASDAQ:UNIS) is one of today's worst performing low-priced stocks, down 8.5% to $4.75 on 1.1x average daily volume. Unilife has traded 1.3 million shares thus far today, vs. average volume of 1.2 million shares per day. The stock has underperformed the Dow (-8.5% to the Dow's -0.5%) and underperformed the S&P 500 (-8.5% to the S&P's -0.8%) during today's trading.
Nasdaq stocks posting largest percentage decreases
AP - Thu Mar 20, 12:54PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:
Top Gainers Technical Data -- Research on First Solar, Oncothyreon, Unilife, and Synthetic Biologics
PR Newswire - Thu Mar 20, 7:07AM CDT
The US markets saw a negative sentiment on Wednesday, March 19, 2014, with the NASDAQ Composite closing at 4,307.60, down 0.59%, the Dow Jones Industrial Average ending the session at 16,222.17, down 0.70% and the S&P 500 edging 0.61% lower to finish the trading session at 1,860.77. The losses were broad based as all the ten sectors ended the session in negative. A number of stocks saw large movements, including First Solar Inc. (NASDAQ: FSLR), Oncothyreon Inc. (NASDAQ: ONTY), Unilife Corp. (NASDAQ: UNIS), and Synthetic Biologics Inc. (AMEX: SYN). Free technical research on FSLR, ONTY, UNIS, and SYN can be downloaded upon signing up at:
Unilife hires Dennis Pyers as interim CFO
M2 - Wed Mar 19, 8:28AM CDT
Drug delivery company Unilife (NASDAQ:UNIS)(ASX:UNS) disclosed on Tuesday that Dennis Pyers (CPA) has been elected as its interim CFO.
Agreements, Financial Results, Clinical Study Results, Debt Financing, and Drug Application Updates - Analyst Notes on Tesaro, Chelsea Therapeutics, Venaxis, Geron, and Unilife
PR Newswire - Wed Mar 19, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Tesaro, Inc. (NASDAQ: TSRO), Chelsea Therapeutics International Ltd. (NASDAQ: CHTP), Venaxis, Inc. (NASDAQ: APPY), Geron Corporation (NASDAQ: GERN), and Unilife Corporation (NASDAQ: UNIS). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Unilife Appoints Dennis Pyers as Interim CFO
PR Newswire - Tue Mar 18, 7:00AM CDT
Unilife Corporation ("Unilife" or "Company"
(NASDAQ: UNIS, ASX: UNS) today announced that Mr. Dennis Pyers, Vice-President and Controller of Unilife since 2010, has been named Interim CFO. Mr. Pyers replaces Mr. Richard Wieland who is leaving Unilife after four years as Executive Vice President and Chief Financial Officer.
5 of Last Week's Biggest Winners
Rick Munarriz, The Motley Fool - Motley Fool - Sun Mar 16, 6:15AM CDT
What's better than momentum? Mo' momentum. Let's take a closer look at five of this past week's biggest scorchers. Company March 14 Weekly Gain CNinsure $8.94 22% UQM Technologies ...
Unilife enters into USD60m debt financing agreement with OrbiMed
M2 - Fri Mar 14, 5:16AM CDT
Drug delivery company Unilife (NASDAQ:UNIS)(ASX:UNS) revealed on Thursday the execution of a USD60m six year debt financing agreement with an affiliate of OrbiMed.
Unilife Up 12.7%, Shares Break Through Resistance (UNIS)
Comtex SmarTrend(R) - Thu Mar 13, 10:18AM CDT
Unilife (NASDAQ:UNIS) is one of today's best performing low-priced stocks, up 12.7% to $4.88 on 1.6x average daily volume. Thus far today, Unilife has traded 1.5 million shares, vs. average volume of 922,000 shares per day. The stock has outperformed the Dow (12.7% to the Dow's -0.2%) and outperformed the S&P 500 (12.7% to the S&P's -0.2%) during today's trading.
Unilife Secures $60 Million Debt Financing with OrbiMed Advisors
PR Newswire - Thu Mar 13, 7:00AM CDT
Unilife Corporation ("Unilife" or "Company" (NASDAQ: UNIS, ASX: UNS) today announced that it has entered into a $60 million debt financing agreement with an affiliate of OrbiMed ("OrbiMed" .
Unilife to Present at the Barclays Global Healthcare Conference on March 13th
PR Newswire - Wed Mar 05, 7:00AM CST
Unilife Corporation ("Unilife" or "Company" (NASDAQ: UNIS, ASX: UNS), today announced that its Chairman and CEO, Alan Shortall, will present at the Barclays Global Healthcare Conference in Miami at 09:00 a.m. ET on Thursday, March 13, 2014.
10-K: API TECHNOLOGIES CORP.
Edgar Online - Wed Feb 12, 3:42PM CST
ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Sport Chalet Recommends Activities For Couples In Pursuit Of Adventure
PR Newswire - Tue Feb 11, 2:13PM CST
Valentine's Day is upon us and everyone is looking for a way to get closer to that special someone. A recent survey conducted by premier specialty sporting goods retailer Sport Chalet found that 95 percent of consumers are more likely to try a new fitness activity if they have a partner to do it with. To help motivate couples to try something new, this Valentine's Day Sport Chalet is encouraging consumers to explore an activity that either builds camaraderie or promotes healthy competition.
Global Prefilled Syringes Market 2013 - 2019
M2 - Tue Apr 15, 8:30AM CDT
Research and Markets (http://www.researchandmarkets.com/research/j3vxcv/prefilled) has announced the addition of the "Global Prefilled Syringes Market 2013 - 2019" report to their offering. The two major segments described in this study are glass-based and plastic-based prefilled syringes. Each of these segments has been analyzed on the basis of their current and future market size in terms of USD million and market volume in terms of million units, considering the macro and micro environmental factors. In addition, the compounded annual growth rate (CAGR) of the overall market and the above segments has also been provided in the report for the forecast period 2013 to 2019, considering 2012 as the base year. Geographically, the market for prefilled syringes has been classified into four regions namely North America, Europe, Asia-Pacific and Rest of the World (RoW). The market size and forecast for each of these regions along with CAGR has also been provided in the report. A detailed qualitative analysis of the major market dynamics such as drivers, restraints and opportunities, along with Porter's five forces analysis and market attractiveness analysis are discussed in the market overview section of the report. The study also suggests a list of recommendations that is likely to help manufacturers in decision making process. The report concludes with a market share analysis of the leading players in the market for prefilled syringes, in terms of percentage share in the year 2012, and company profiles of the key players. The market players profiled in this report are Becton, Dickinson and Company, Gerresheimer AG, Nipro Corporation, Schott AG, Stevanato Group, Baxter, International, Inc., Unilife Corporation, West Pharmaceutical Services, Inc., Bespak, Ypsomed Holding AG and Vetter Pharma International GmbH. Scope of the Report Segment - Glass Prefilled Syringes Market - - By Revenue (USD Million) - - By Volume (Million units) - Plastic Prefilled Syringes Market - - By Revenue (USD Million) - - By Volume (Million units) Key Topics Covered: - Preface - Executive Summary - Global Prefilled Syringes Market Overview - Global Prefilled Syringes Market Revenue (USD Million) and Volume (Million Units), by Segment, 2011 - 2019 - Global Prefilled Syringes Market Revenue (USD Million) and Volume (Million Units), by Geography, 2011 - 2019 - Competitive Landscape - Recommendations - Company Profiles - Baxter International, Inc - Becton, Dickinson & Company - Bespak - Gerresheimer AG - Nipro Corporation - Schott AG - Stevanato Group - Unilife Corporation - Vetter Pharma International GmbH - West Pharmaceutical Services, Inc - Ypsomed Holding AG For more information visit http://www.researchandmarkets.com/research/j3vxcv/prefilled
Health Care Sector Equities Update -- Research on Endologix, Align Technology, Spectranetics, and Unilife
PR Newswire - Mon Apr 14, 8:00AM CDT
The trading session on Friday, April 11, 2014 ended on a lower note as the Dow Jones Industrial Average finished at 16,026.75, down 0.89% and the NASDAQ Composite closed at 3,999.73, down 1.34%. The S&P 500 finished the session 0.95% lower at 1,815.69. The losses were broad based as all the ten sectors posted losses. The S&P 500 Health Care Sector Index finished the day at 644.74, down 1.07%, and the same has declined 2.36% in last three months. Investor-Edge has initiated coverage on the following equities: Endologix Inc. (NASDAQ: ELGX), Align Technology Inc. (NASDAQ: ALGN), Spectranetics Corp. (NASDAQ: SPNC) and Unilife Corp. (NASDAQ: UNIS). Free technical research on ELGX, ALGN, SPNC and UNIS can be downloaded upon signing up at:
Commit To Purchase Unilife Corp. At $2.50, Earn 13.4% Annualized Using Options
StockOptionsChannel.com - Thu Apr 10, 10:51AM CDT
Investors eyeing a purchase of Unilife Corp. shares, but cautious about paying the going market price of $3.62/share, might benefit from considering selling puts among the alternative strategies at their disposal.
European Commission Approves Exelixis Inc.'s Therapy for Thyroid Cancer
ACCESSWIRE - Fri Apr 04, 1:00PM CDT
Exelixis Inc. (NASDAQ:EXEL) enjoyed robust stock volume Apr. 3, with 4,756,727 shares changing hands.
Unilife Down 5.1%, Shares Slide into the Red (UNIS)
Comtex SmarTrend(R) - Fri Mar 28, 10:41AM CDT
Unilife (NASDAQ:UNIS) is one of today's worst performing low-priced stocks, down 5.1% to $4.11 on 1.1x average daily volume. Unilife has traded 1.3 million shares thus far today, vs. average volume of 1.2 million shares per day. The stock has underperformed the Dow (-5.1% to the Dow's 0.7%) and underperformed the S&P 500 (-5.1% to the S&P's 0.8%) during today's trading.
Investors look to Lighten Up on Shares of Unilife, Shares Down 8.5% (UNIS)
Comtex SmarTrend(R) - Mon Mar 24, 11:42AM CDT
Unilife (NASDAQ:UNIS) is one of today's worst performing low-priced stocks, down 8.5% to $4.75 on 1.1x average daily volume. Unilife has traded 1.3 million shares thus far today, vs. average volume of 1.2 million shares per day. The stock has underperformed the Dow (-8.5% to the Dow's -0.5%) and underperformed the S&P 500 (-8.5% to the S&P's -0.8%) during today's trading.
Nasdaq stocks posting largest percentage decreases
AP - Thu Mar 20, 12:54PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:
Top Gainers Technical Data -- Research on First Solar, Oncothyreon, Unilife, and Synthetic Biologics
PR Newswire - Thu Mar 20, 7:07AM CDT
The US markets saw a negative sentiment on Wednesday, March 19, 2014, with the NASDAQ Composite closing at 4,307.60, down 0.59%, the Dow Jones Industrial Average ending the session at 16,222.17, down 0.70% and the S&P 500 edging 0.61% lower to finish the trading session at 1,860.77. The losses were broad based as all the ten sectors ended the session in negative. A number of stocks saw large movements, including First Solar Inc. (NASDAQ: FSLR), Oncothyreon Inc. (NASDAQ: ONTY), Unilife Corp. (NASDAQ: UNIS), and Synthetic Biologics Inc. (AMEX: SYN). Free technical research on FSLR, ONTY, UNIS, and SYN can be downloaded upon signing up at:
Unilife hires Dennis Pyers as interim CFO
M2 - Wed Mar 19, 8:28AM CDT
Drug delivery company Unilife (NASDAQ:UNIS)(ASX:UNS) disclosed on Tuesday that Dennis Pyers (CPA) has been elected as its interim CFO.
Agreements, Financial Results, Clinical Study Results, Debt Financing, and Drug Application Updates - Analyst Notes on Tesaro, Chelsea Therapeutics, Venaxis, Geron, and Unilife
PR Newswire - Wed Mar 19, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Tesaro, Inc. (NASDAQ: TSRO), Chelsea Therapeutics International Ltd. (NASDAQ: CHTP), Venaxis, Inc. (NASDAQ: APPY), Geron Corporation (NASDAQ: GERN), and Unilife Corporation (NASDAQ: UNIS). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Unilife Appoints Dennis Pyers as Interim CFO
PR Newswire - Tue Mar 18, 7:00AM CDT
Unilife Corporation ("Unilife" or "Company"
(NASDAQ: UNIS, ASX: UNS) today announced that Mr. Dennis Pyers, Vice-President and Controller of Unilife since 2010, has been named Interim CFO. Mr. Pyers replaces Mr. Richard Wieland who is leaving Unilife after four years as Executive Vice President and Chief Financial Officer. 5 of Last Week's Biggest Winners
Rick Munarriz, The Motley Fool - Motley Fool - Sun Mar 16, 6:15AM CDT
What's better than momentum? Mo' momentum. Let's take a closer look at five of this past week's biggest scorchers. Company March 14 Weekly Gain CNinsure $8.94 22% UQM Technologies ...
Unilife enters into USD60m debt financing agreement with OrbiMed
M2 - Fri Mar 14, 5:16AM CDT
Drug delivery company Unilife (NASDAQ:UNIS)(ASX:UNS) revealed on Thursday the execution of a USD60m six year debt financing agreement with an affiliate of OrbiMed.
Unilife Up 12.7%, Shares Break Through Resistance (UNIS)
Comtex SmarTrend(R) - Thu Mar 13, 10:18AM CDT
Unilife (NASDAQ:UNIS) is one of today's best performing low-priced stocks, up 12.7% to $4.88 on 1.6x average daily volume. Thus far today, Unilife has traded 1.5 million shares, vs. average volume of 922,000 shares per day. The stock has outperformed the Dow (12.7% to the Dow's -0.2%) and outperformed the S&P 500 (12.7% to the S&P's -0.2%) during today's trading.
Unilife Secures $60 Million Debt Financing with OrbiMed Advisors
PR Newswire - Thu Mar 13, 7:00AM CDT
Unilife Corporation ("Unilife" or "Company"
(NASDAQ: UNIS, ASX: UNS) today announced that it has entered into a $60 million debt financing agreement with an affiliate of OrbiMed ("OrbiMed" . Unilife to Present at the Barclays Global Healthcare Conference on March 13th
PR Newswire - Wed Mar 05, 7:00AM CST
Unilife Corporation ("Unilife" or "Company"
(NASDAQ: UNIS, ASX: UNS), today announced that its Chairman and CEO, Alan Shortall, will present at the Barclays Global Healthcare Conference in Miami at 09:00 a.m. ET on Thursday, March 13, 2014. 10-K: API TECHNOLOGIES CORP.
Edgar Online - Wed Feb 12, 3:42PM CST
ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Sport Chalet Recommends Activities For Couples In Pursuit Of Adventure
PR Newswire - Tue Feb 11, 2:13PM CST
Valentine's Day is upon us and everyone is looking for a way to get closer to that special someone. A recent survey conducted by premier specialty sporting goods retailer Sport Chalet found that 95 percent of consumers are more likely to try a new fitness activity if they have a partner to do it with. To help motivate couples to try something new, this Valentine's Day Sport Chalet is encouraging consumers to explore an activity that either builds camaraderie or promotes healthy competition.
